Sabina Paglialunga

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Robert M Lester, Caroline Engel, Aernout D van Haarst, Sabina Paglialunga
Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability. Clinical pharmacology and therapeutics (2024)
Robert M Lester, Caroline Engel, Aernout D van Haarst, Sabina Paglialunga
Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability. Clinical pharmacology and therapeutics 116 (1) (2024)
Sumit Kar, Sabina Paglialunga, Sharon H Jaycox, Rafiqul Islam, Angelo H Paredes
Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PloS one 14 (7) (2019)